Along with others, Zinovkin and Grebenchikov are now conducting clinical trials to test Nrf2 inducers for preventing and treating the cytokine storm associated with severe cases of COVID-19 disease.

“If our clinical trials are successful, AVA-Trap and CB-MSC-1 could both make a difference for COVID-19 patients—AVA-Trap for those with a cytokine storm and MSC therapies for individuals who ...

In an intensive genomic search for causes of cytokine storm, the research team used autopsy samples obtained from 40 patients who died from COVID-19. They performed genome analysis on samples ...

A cytokine storm is a severe immune response that causes ... However, as the situation surrounding COVID-19 continues to evolve, it's possible that some data have changed since publication.

Diseases such as covid-19 and influenza can be fatal due to an overreaction of the body’s immune system called a cytokine storm. Cytokines are small proteins released by many different cells in ...

This "cytokine storm" prompts white blood cells to attack healthy lung tissue. The reaction may cause milder coronavirus symptoms like fever, fatigue, muscle aches, or purple, swollen toes.

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.